Targeting NKG2D ligands in glioblastoma with a bispecific T-cell engager is augmented with conventional therapy and enhances oncolytic virotherapy of glioma stem-like cells by Daniel Ebner, Olaf Ansorge, Hena Khalique, Richard Baugh, Janet Lei-Rossmann, Emma Page, Peter Kok-Ting Wan, Leonard W Seymour, Timothy Johanssen

Get full text